stocknews1d
3 Biotech Stocks Revolutionizing Healthcare
Driven by rapid innovations and the integration of modern technologies, the biotech sector is experiencing robust growth.
GlobalData on MSN4d
Amgen opens new drug substance facility in North Carolina, US
Situated in the core of the NC Research Triangle, the site at Camp Helix Innovation Park is a substantial regional investment ...
ascopubs.org4d
Outcomes of simultaneous, adaptive, MRI-guided liver SBRT in patients with heavily pretreated colorectal cancer and four or more liver metastases.
The crossover of the bevacizumab and panitumumab survival curves in the PARADIGM study: A clue to time-related effects of bevacizumab on the risk of tumor progression. Risk of peritoneal recurrence ...
ascopubs.org4d
Phase I/II study of cabozantinib alone or in combination with panitumumab in patients with MET-amplified metastatic colorectal cancer.
This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal Cancers Symposium. This abstract does not include a full text component.
oncnursingnews6d
Bevacizumab’s Benefit in Colorectal Cancer May Be Limited to 2 Years Post-Administration
The 2-year benefit of bevacizumab in colorectal cancer may explain why survival benefits are seen in studies with two-year, ...
Yahoo Finance4d
Amgen Inc. (AMGN)
After hours: 7:50:10 p.m. EST ...